科技赋能+标准引领 吉林敖东加速推动中医药产业创新转型

Group 1 - Jilin Aodong Pharmaceutical Group actively participated in the "Hundred Enterprises Connect Hundred Villages" initiative, donating essential medicines worth RMB 594,900 to nine poverty alleviation villages in Tibet [1] - The donated medicines include four types of urgently needed common drugs, which will be distributed to 1,147 farming and pastoral households, enhancing local healthcare resources [1] - The company is committed to the development of traditional Chinese medicine (TCM) through innovation and industry upgrades, integrating traditional characteristics with modern elements [1] Group 2 - Jilin Aodong focuses on core research of traditional Chinese medicinal materials, advancing into anti-aging and regenerative medicine, and transitioning TCM from "experience inheritance" to "scientific decoding" [2] - The company has obtained two significant invention patents, upgrading core products to meet high-quality health consumption demands [2] - Jilin Aodong is enhancing the entire TCM industry chain's intelligent upgrade through new production capabilities, utilizing biotechnologies and smart management systems for better quality control [2] Group 3 - The company has secured 525 filing certificates in the TCM granule sector and is leading industry standard research in collaboration with universities, filling market gaps and guiding industry development [3] - Jilin Aodong is reconstructing a health ecosystem centered around deer antler, significantly increasing the knowledge density and value of the entire industry chain [3] - The company aims to drive industry upgrades through technological innovation and standardization, aligning with the "Healthy China" strategy and the 14th Five-Year Plan [3]